Expert insight:

Video: How much is a payer willing to pay for a QALY gain? – By Prof. Dr. Lieven Annemans


In the below 2-min video, Prof. Dr. Lieven Annemans explains how payers decide on reimbursing a new treatment based on the number of QALYs gained, and how that differs between countries. It’s a great video with animation!

 

 

Attend Lieven’s popular 2-day CELforPharma course Health Economics for Non-Health-Economists if you want to be able to understand and discuss the health economic evaluation studies of your brands (or of its competitors), and be able to have meaningful HECON conversations with external and internal stakeholders.

Last update: May 2020

 

➤ More info on the 'Health Economics for Non-Health-Economists' course

➤ More info on other Market Access, Pricing & Health Economics courses